A take a look at the weighted underlying holdings of the SPDR— S&P— Prescription drugs ETF (XPH) reveals a formidable 11.4% of holdings on a weighted foundation have skilled insider shopping for throughout the previous six months.
Axsome Therapeutics Inc (Image: AXSM), which makes up 3.72% of the SPDR— S&P— Prescription drugs ETF (XPH), has seen 2 administrators and officers buy shares prior to now six months, in keeping with the current Type Four knowledge. The ETF holds a complete of $9,640,469 price of AXSM, making it the #15 largest holding. The desk beneath particulars the current insider shopping for exercise noticed at AXSM:
AXSM — final commerce: $79.32 — Current Insider Buys:
| Bought | Insider | Title | Shares | Value/Share | Worth |
|---|---|---|---|---|---|
| 06/29/2020 | Mark Coleman | Director | 650 | $78.50 | $51,025 |
| 06/29/2020 | Nick Pizzie | Chief Monetary Officer | 777 | $76.64 | $59,549 |
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.